Despite Surging Earnings Sanofi-Aventis is Restructuring and Planning Layoffs

Reuters reports that French drug maker Sanofi-Aventis (S-A) beat analysts second-quarter earning forecasts and that next year’s earnings will likely benefit from increased demand for its new H1NI swine flu vaccine. The company is the largest flu vaccine manufacturer in the world. Yet, despite surging profits, S-A continues to restructure and cut jobs in an effort maintain its stock share price. —and an “impeccable source”— that US managers are in France discussing cuts to American operations. The cuts are expected to be announced during the first week of August. More bad news for the US economy and  tens of thousands of American pharmaceutical employees who have already lost their jobs.

Until next time

SocialTwist Tell-a-Friend

Good Luck and Good Job Hunting????????

 

Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.biojobblog.com/admin/trackback/148093
Comments (1) Read through and enter the discussion with the form at the end
Vanessa - August 2, 2009 12:10 AM

Why does Sanofi - Aventis have over 266 sales positions posted just this week across the USA?
Are you saying they are going to be laying off, but allowing some of the displaced reps the opportunity to apply for these new positions?
Why advertise a position? Just offer it to the best internal candidate that fits the job description.

Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.